Sluggish exports may cap pharma YoY revenue growth in FY22, says Crisil

New Delhi, Nov 16 (IANS) Revenue growth of India's pharmaceutical sector is expected to "moderate" to 9 per cent in FY22, as compared with a healthy rise of 12.5 per cent during the previous fiscal, ...

Become a proud member of 1947.com to access this content.